U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196293) titled 'A Comparison Between Protemp and Flowable Light Cure Composite Material for Creating Optim... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196644) titled 'A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years o... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197658) titled 'Healing After Endodontic Microsurgery Using a Rotary Bur Versus Piezoelectric Unit for Ost... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197606) titled 'Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke' on Se... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196111) titled 'BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors' on Sept. 19. Brief Summary: ... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07195760) titled 'Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196124) titled 'BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma' on Sept. 19. Brief Summary: This study is... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197008) titled 'Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Adva... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196618) titled 'Bond Strength Evaluation' on Aug. 09. Brief Summary: This study was evaluated the effect ... Read More
U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197697) titled 'A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in... Read More